YOLFTbeta
Heilongjiang ZBD Pharmaceutical Co Ltd

Heilongjiang ZBD Pharmaceutical Co Ltd

603567 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

4.71CNY-0.18 (-3.68%)

Price History

Full chart

Market Stats

Previous Close4.89
Open4.90
Day Range4.70 – 4.92
52-Week Range4.21 – 12.30
Volume17.02M
Market Cap4.95B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.66
Dividend Yield0.00%
Beta0.20
50-Day Avg5.91
200-Day Avg6.95

About

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufacturing of pharmaceuticals; pharmaceutical retail and wholesale; testing and inspection services; pharmaceutical internet information services; laboratory animal production; and laboratory animal management. The company offers medicines in the field of cardiovascular and cerebrovascular, anti-infectives, respiratory system drugs, tumors, and antiviral drugs diseases. Heilongjiang ZBD Pharmaceutical Co., Ltd. was founded in 1996 and is based in Harbin, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Tianzhu Li
  • Employees1.96K
  • HeadquartersNo. 8, Yantai Road, Harbin, China, 150060, China
  • Websitehttps://www.zbdzy.com

Leadership

  • Ms. Tianzhu LiDeputy General Manager · b. 1978
  • Ji LangInvestor Relations Director

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.07B1.38B1.41B1.59B2.07B2.39B3.14B2.78B3.29B3.40B4.13B4.21B3.14B2.70B798.06M
Growth (%)-+28.79%+2.54%+12.59%+30.14%+15.35%+31.17%-11.34%+18.37%+3.40%+21.24%+2.12%-25.53%-13.84%-70.49%
Cost of Revenue470.07M577.93M486.20M617.38M492.61M892.24M1.38B867.72M1.39B1.52B2.83B3.54B1.85B1.33B820.12M
Gross Profit601.20M801.77M928.60M975.54M1.58B1.50B1.75B1.91B1.91B1.89B1.30B675.25M1.29B1.37B-22.06M
Gross Margin56.12%58.11%65.63%61.24%76.24%62.69%55.86%68.80%57.92%55.48%31.45%16.02%41.18%50.67%-2.76%
Operating Expense256.32M324.12M434.46M462.47M912.16M1.01B1.10B1.34B1.36B1.38B841.86M377.73M819.15M846.70M395.80M
Operating Income344.89M477.65M494.14M513.06M668.29M491.30M647.93M574.23M547.35M510.55M456.12M297.53M473.24M523.26M-417.86M
Operating Margin32.19%34.62%34.93%32.21%32.24%20.55%20.66%20.65%16.63%15.00%11.05%7.06%15.08%19.35%-52.36%
EBITDA424.26M541.21M654.43M650.46M823.30M609.58M736.52M749.43M704.85M741.23M405.93M-59.75M364.32M756.94M-1.31B
EBITDA Margin39.60%39.23%46.26%40.83%39.71%25.49%23.48%26.95%21.41%21.78%9.84%-1.42%11.61%27.99%-164.63%
Net Income296.06M389.65M436.90M477.30M585.31M509.56M520.87M462.44M408.65M436.29M332.10M185.44M472.74M438.22M-1.37B
Net Income Margin27.64%28.24%30.88%29.96%28.23%21.31%16.61%16.63%12.41%12.82%8.05%4.40%15.06%16.21%-171.23%
R&D-62.11M58.34M67.65M92.97M70.93M93.74M90.91M86.50M81.34M55.23M70.95M80.22M37.99M46.35M
R&D as % of Total Revenue-4.50%4.12%4.25%4.48%2.97%2.99%3.27%2.63%2.39%1.34%1.68%2.56%1.41%5.81%
Interest Expense20.10M24.27M46.64M60.08M50.94M53.28M51.51M63.67M117.49M151.56M147.88M141.65M135.41M145.12M139.00M
Interest Expense % of Total Revenue1.88%1.76%3.30%3.77%2.46%2.23%1.64%2.29%3.57%4.45%3.58%3.36%4.31%5.37%17.42%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.44B2.13B3.25B3.60B5.95B6.42B6.89B8.18B9.02B10.23B11.51B11.68B12.47B12.71B10.63B
Total Liabilities516.70M808.30M1.50B1.43B1.97B2.11B2.21B3.20B3.77B4.73B4.45B4.57B4.43B4.42B4.36B
Total Equity923.09M1.31B1.75B2.19B4.00B4.30B4.67B4.97B5.24B5.49B7.04B7.10B7.55B7.80B6.28B
Cash52.33M121.96M634.84M566.34M1.70B1.18B1.80B2.25B2.55B1.54B1.55B1.00B1.45B1.05B78.91M
Total Debt336.70M515.00M1.06B750.00M1.03B1.43B1.40B2.15B2.69B3.21B2.94B2.93B3.15B2.85B-
Net Debt284.37M393.04M430.16M183.66M-669.10M251.83M-397.67M-104.86M132.13M1.67B1.39B1.92B1.70B1.80B1.28B

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow104.71M154.25M174.68M386.32M-323.90M15.83M853.19M367.40M220.92M155.18M-433.94M-326.79M-457.90M164.31M322.10M
Investing Cash Flow-146.76M-238.74M-171.35M-69.60M-449.09M-304.56M-30.49M-433.77M-260.76M-1.45B-421.26M283.93M176.43M-106.02M-
Financing Cash Flow-25.59M154.13M509.54M-416.30M1.56B142.23M-229.65M517.94M328.82M292.11M797.46M-418.94M765.69M-454.16M-
Capital Expenditure139.77M233.09M168.73M79.85M69.96M318.74M492.42M419.59M178.79M868.65M448.63M404.27M95.14M189.15M68.52M
Free Cash Flow-35.06M-78.84M5.96M306.47M-393.86M-302.92M360.77M-52.19M42.14M-713.47M-882.57M-731.07M-573.38M-24.84M253.57M
Dividends Paid22.29M25.21M43.46M101.30M248.39M265.18M202.26M232.69M139.26M184.27M143.73M99.85M158.28M324.28M276.56M
FCF to OCF-33.48%-51.12%3.41%79.33%121.60%-1914.11%42.28%-14.20%19.07%-459.78%203.39%223.71%125.22%-15.12%78.73%
Dividend Paid to FCF-63.59%-31.97%729.50%33.05%-63.07%-87.54%56.06%-445.88%330.49%-25.83%-16.28%-13.66%-27.60%-1305.28%109.07%

Earnings

Report DateSep 30, 2015Dec 31, 2015Mar 31, 2016Aug 25, 2016Sep 30, 2016Dec 31, 2016Apr 28, 2017Aug 18, 2017Oct 25, 2017Dec 31, 2017Apr 25, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Apr 25, 2019Aug 24, 2019Oct 30, 2019Dec 31, 2019Apr 29, 2020Aug 11, 2020Oct 29, 2020Dec 31, 2020Apr 29, 2021Aug 21, 2021Oct 29, 2021Dec 31, 2021Apr 29, 2022Aug 25, 2022Oct 27, 2022Dec 31, 2022Apr 28, 2023
EPS Estimate-------------------------------
EPS Actual0.060.340.070.170.200.150.140.100.180.200.180.110.150.110.200.080.120.080.150.070.070.230.180.14-0.040.100.170.09-0.090.030.03
Surprise-------------------------------
Timing---After-hours--After-hoursAfter-hoursPre-market-Pre-market---After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hours---Pre-marketAfter-hoursPre-market-Pre-market

Key Statistics & Ratios

Market Cap4.95B
Enterprise Value8.07B
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.04
Price / Book0.83
EPS-1.66
Book Value6.41
Revenue (TTM)379.28M
Gross Profit (TTM)-663.69M
EBITDA-1.20B
Profit Margin0.00%
Operating Margin-54.21%
Return on Equity-22.65%
Return on Assets-7.57%
Shares Outstanding940.24M
Shares Float388.16M
Beta0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio85.51%

Dividends

20231×
0.03Jun 15, 2023
20221×
0.11Jun 7, 2022
20201×
0.22Jun 4, 2020
20191×
0.16Jun 4, 2019
20181×
0.18Jun 1, 2018
20171×
0.18Jun 7, 2017
20161×
0.50Jun 13, 2016

Stock Splits

  • Jun 13, 20162:1